Whole genome deconvolution unveils Alzheimer's resilient epigenetic signature

E Berson, A Sreenivas, T Phongpreecha… - Nature …, 2023 - nature.com
Abstract Assay for Transposase Accessible Chromatin by sequencing (ATAC-seq)
accurately depicts the chromatin regulatory state and altered mechanisms guiding gene …

Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion

X Xiong, BT James, CA Boix, YP Park, K Galani… - Cell, 2023 - cell.com
Recent work has identified dozens of non-coding loci for Alzheimer's disease (AD) risk, but
their mechanisms and AD transcriptional regulatory circuitry are poorly understood. Here …

A comparative atlas of single-cell chromatin accessibility in the human brain

YE Li, S Preissl, M Miller, ND Johnson, Z Wang, H Jiao… - Science, 2023 - science.org
Recent advances in single-cell transcriptomics have illuminated the diverse neuronal and
glial cell types within the human brain. However, the regulatory programs governing cell …

The three-dimensional landscape of cortical chromatin accessibility in Alzheimer's disease

J Bendl, ME Hauberg, K Girdhar, E Im, JM Vicari… - Nature …, 2022 - nature.com
To characterize the dysregulation of chromatin accessibility in Alzheimer's disease (AD), we
generated 636 ATAC-seq libraries from neuronal and nonneuronal nuclei isolated from the …

Characterizing dysregulations via cell-cell communications in Alzheimer's brains using single-cell transcriptomes

CY Lee, D Riffle, Y Xiong, N Momtaz, Y Lei… - BMC neuroscience, 2024 - Springer
Background Alzheimer's disease (AD) is a devastating neurodegenerative disorder affecting
44 million people worldwide, leading to cognitive decline, memory loss, and significant …

Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease

S Morabito, E Miyoshi, N Michael… - Human molecular …, 2020 - academic.oup.com
Alzheimer's disease (AD) is a devastating neurological disorder characterized by changes in
cell-type proportions and consequently marked alterations of the transcriptome. Here we use …

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer's disease

T Luquez, P Gaur, IM Kosater, M Lam, DI Lee, J Mares… - Genome Medicine, 2022 - Springer
The rapid advancement of single-cell transcriptomics in neurology has allowed for profiling
of post-mortem human brain tissue across multiple diseases. Over the past 3 years, several …

A single-cell and spatial RNA-seq database for Alzheimer's disease (ssREAD)

C Wang, D Acosta, M McNutt, J Bian, A Ma… - Nature …, 2024 - nature.com
Alzheimer's Disease (AD) pathology has been increasingly explored through single-cell and
single-nucleus RNA-sequencing (scRNA-seq & snRNA-seq) and spatial transcriptomics …

Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer's disease dataset

AE Murphy, N Fancy, N Skene - Elife, 2023 - elifesciences.org
Mathys et al. conducted the first single-nucleus RNA-seq (snRNA-seq) study of Alzheimer's
disease (AD)(Mathys et al., 2019). With bulk RNA-seq, changes in gene expression across …

Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers

L Brase, SF You, R D'Oliveira Albanus… - Nature …, 2023 - nature.com
Genetic studies of Alzheimer disease (AD) have prioritized variants in genes related to the
amyloid cascade, lipid metabolism, and neuroimmune modulation. However, the cell …